Pediatric Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis, Diagnostic Advances, and Modern Therapeutic Approaches
Keywords:
Pediatric inflammatory bowel disease, Crohn’s disease, ulcerative colitis, intestinal inflammation, fecal calprotectin, endoscopy, biologic therapy, mucosal healing, pediatric gastroenterology.Abstract
Pediatric inflammatory bowel disease (IBD) is a chronic, immune-mediated disorder of the gastrointestinal tract that primarily includes Crohn’s disease (CD) and ulcerative colitis (UC). These conditions represent an important challenge in pediatric medicine because they may interfere with growth, nutritional status, puberty, psychological development, and quality of life. Although Crohn’s disease and ulcerative colitis share several clinical manifestations, they differ in anatomical distribution, pathological characteristics, and long-term complications. Crohn’s disease can affect any part of the gastrointestinal tract and is associated with transmural inflammation, strictures, fistulas, and perianal disease. Ulcerative colitis mainly involves continuous mucosal inflammation of the colon, frequently presenting with bloody diarrhea, urgency, and abdominal discomfort. Recent advances in pediatric gastroenterology have improved diagnostic accuracy through fecal calprotectin, endoscopic evaluation, histopathology, magnetic resonance enterography, and intestinal ultrasound. Treatment has shifted from controlling symptoms alone toward a treat-to-target strategy focused on sustained clinical remission, biochemical control, mucosal healing, normal growth, and prevention of intestinal damage. Nutritional therapy, corticosteroids, immunomodulators, biologic agents, targeted small molecules, and surgery are used according to disease severity and individual risk factors. Early recognition, multidisciplinary care, and personalized treatment are essential for improving long-term outcomes in children with IBD.
References
Levine A, Koletzko S, Turner D, et al. ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents. Journal of Pediatric Gastroenterology and Nutrition. 2014;58(6):795–806.
2. Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease. Gastroenterology. 2021;160(5):1570–1583.
3. Turner D, Ruemmele FM, Orlanski-Meyer E, et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care—An Updated Evidence-Based Consensus Guideline from ESPGHAN and ECCO. Journal of Pediatric Gastroenterology and Nutrition. 2025;81(3):765–815.
4. Ruemmele FM, Veres G, Kolho KL, et al. Consensus Guidelines of ECCO/ESPGHAN on the Medical Management of Pediatric Crohn’s Disease. Journal of Crohn’s and Colitis. 2014;8(10):1179–1207.
5. van Rheenen PF, Aloi M, Assa A, et al. The Medical Management of Paediatric Crohn’s Disease: An ECCO-ESPGHAN Guideline Update. Journal of Crohn’s and Colitis. 2021;15(2):171–194.